Home  »  Industry   »  Catalyst Biosciences Inc. (CBIO): Is this the Most...

Catalyst Biosciences Inc. (CBIO): Is this the Most Sought-After Stock Today?

For the readers interested in the stock health of Catalyst Biosciences Inc. (CBIO). It is currently valued at $0.30. When the transactions were called off in the previous session, Stock hit the highs of $0.32, after setting-off with the price of $0.278. Company’s stock value dipped to $0.2739 during the trading on the day. When the trading was stopped its value was $0.27.Recently in News on December 27, 2022, Catalyst Biosciences Completes First Steps in Reverse Merger Plan. Acquires F351, a Phase 3 Drug to Treat Fibrosis. You can read further details here

Catalyst Biosciences Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $0.6500 on 01/09/23, with the lowest value was $0.1950 for the same time period, recorded on 01/13/23.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…


Catalyst Biosciences Inc. (CBIO) full year performance was 185.16%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Catalyst Biosciences Inc. shares are logging -26.19% during the 52-week period from high price, and 421.28% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.06 and $0.40.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1609636 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Catalyst Biosciences Inc. (CBIO) recorded performance in the market was -9.05%, having the revenues showcasing -16.82% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 10.46M, as it employees total of 45 workers.

Analysts verdict on Catalyst Biosciences Inc. (CBIO)

During the last month, 0 analysts gave the Catalyst Biosciences Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.7241, with a change in the price was noted -1.66. In a similar fashion, Catalyst Biosciences Inc. posted a movement of -84.85% for the period of last 100 days, recording 796,745 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for CBIO is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

Catalyst Biosciences Inc. (CBIO): Technical Analysis

Raw Stochastic average of Catalyst Biosciences Inc. in the period of last 50 days is set at 22.42%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 22.42%. In the last 20 days, the company’s Stochastic %K was 18.21% and its Stochastic %D was recorded 15.42%.

Let’s take a glance in the erstwhile performances of Catalyst Biosciences Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -9.05%. Additionally, trading for the stock in the period of the last six months notably improved by 3.69%, alongside a boost of 185.16% for the period of the last 12 months. The shares increased approximately by 16.61% in the 7-day charts and went up by -4.05% in the period of the last 30 days. Common stock shares were lifted by -16.82% during last recorded quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts